首页> 外文会议>Colloidal nanocrystals for biomedical applications VII >Biodegradable Polymer Nanocarriers for Therapeutic Antisense microRNA Delivery in Living Animals
【24h】

Biodegradable Polymer Nanocarriers for Therapeutic Antisense microRNA Delivery in Living Animals

机译:可治疗动物反义microRNA的可生物降解聚合物纳米载体。

获取原文
获取原文并翻译 | 示例

摘要

MicroRNAs are endogenous regulators of gene expression, deregulated in several cellular diseases including cancer. Altering the cellular microenvironment by modulating the microRNAs functions can regulate different genes involved in major cellular processes, and this approach is now being investigated as a promising new generation of molecularly targeted anti-cancer therapies. AntagomiRs (Antisense-miRNAs) are a novel class of chemically modified stable oligonucleotides used for blocking the functions of endogenous microRNAs, which are overexpressed. A key challenge in achieving effective microRNA-based therapeutics lies in the development of an efficient delivery system capable of specifically delivering antisense oligonucleotides and target cancer cells in living animals. We are now developing an effective delivery system designed to selectively deliver antagomiR-21 and antagomiR-10b to triple negative breast cancer cells, and to revert tumor cell metastasis and invasiveness. The FDA-approved biodegradable PLGA-nanoparticles were selected as a carrier for antagomiRs delivery. Chemically modified antagomiRs (antagomiR-21 and antagomiR-10b) were co-encapsulated in PEGylated-PLGA-nanoparticles by using the double-emulsification (W/O/W) solvent evaporation method, and the resulting average particle size of 150-200nm was used for different in vitro and in vivo experiments. The antagomiR encapsulated PLGA-nanoparticles were evaluated for their in vitro antagomiRs delivery, intracellular release profile, and antagomiRs functional effects, by measuring the endogenous cellular targets, and the cell growth and metastasis. The xenografts of tumor cells in living mice were used for evaluating the anti-metastatic and anti-invasive properties of cells. The results showed that the use of PLGA for antagomiR delivery is not only efficient in crossing cell membrane, but can also maintain functional intracellular antagomiRs level for a extended period of time and achieve therapeutic effect in living animals.
机译:MicroRNA是基因表达的内源性调节因子,在包括癌症在内的多种细胞疾病中均被解除调控。通过调节microRNA的功能来改变细胞的微环境可以调节参与主要细胞过程的不同基因,这种方法目前正在作为一种有前途的新一代分子靶向抗癌疗法进行研究。 AntagomiRs(Antisense-miRNA)是一类新型的化学修饰的稳定寡核苷酸,用于阻断过表达的内源性microRNA的功能。实现有效的基于microRNA的疗法的关键挑战在于开发能够在活体动物中特异性递送反义寡核苷酸和靶向癌细胞的有效递送系统。我们现在正在开发一种有效的递送系统,旨在选择性地将antagomiR-21和antagomiR-10b递送至三阴性乳腺癌细胞,并逆转肿瘤细胞的转移和侵袭性。选择了FDA批准的可生物降解PLGA纳米颗粒作为AntagomiRs递送的载体。通过使用双乳化(W / O / W)溶剂蒸发法将化学修饰的antagomiRs(antagomiR-21和antagomiR-10b)共包裹在PEG化PLGA纳米颗粒中,得到的平均粒径为150-200nm用于不同的体外和体内实验。通过测量内源性细胞靶标以及细胞生长和转移,评估了antagomiR封装的PLGA纳米颗粒的体外antagomiRs递送,细胞内释放曲线和antagomiRs功能作用。用活小鼠的肿瘤细胞异种移植物评估细胞的抗转移和抗侵袭特性。结果表明,使用PLGA传递antagomiR不仅可以有效地穿过细胞膜,而且可以长时间维持功能性细胞内antagomiRs的水平,并在活体动物中达到治疗效果。

著录项

  • 来源
    《Colloidal nanocrystals for biomedical applications VII》|2012年|p.823208.1-823208.13|共13页
  • 会议地点 San Francisco CA(US)
  • 作者单位

    Molecular Imaging Program at Stanford, Bio-X Program, Stanford University School of Medicine, Stanford, California, USA,Department of Radiology, Stanford University School of Medicine 1501, South California Avenue, #2217 □Palo Alto, CA 94304;

    Molecular Imaging Program at Stanford, Bio-X Program, Stanford University School of Medicine, Stanford, California, USA;

    Molecular Imaging Program at Stanford, Bio-X Program, Stanford University School of Medicine, Stanford, California, USA;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医用物理学;
  • 关键词

    antagomiR; antisense microRNA;

    机译:antagomiR;反义microRNA;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号